Genomic Profile and BRCA-1 Promoter Methylation Status in BRCA Mutated Ovarian Cancer: New Insights in Predictive Biomarkers of Olaparib Response

Objective: We assessed the genomic profile of four representative BRCA-mutated ovarian cancer (OC) patients treated with olaparib to investigate the relationship between intratumor heterogeneity and response to olaparib treatment. The main aim is to identify possible predictive biomarkers of respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Franzese, Elisena, Centonze, Sara, Diana, Anna, Lombardi, Angela, Carlino, Francesca, Guerrera, Luigi Pio, De Vita, Ferdinando, Caraglia, Michele, Pignata, Sandro, Ciardiello, Fortunato, Orditura, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895028/
https://www.ncbi.nlm.nih.gov/pubmed/31850198
http://dx.doi.org/10.3389/fonc.2019.01289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895028/
https://www.ncbi.nlm.nih.gov/pubmed/31850198
http://dx.doi.org/10.3389/fonc.2019.01289

Ejemplares similares